Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10751333 | 0.91 | TSHR (0.42) | USP2HTTFFAR4FFAR1TSHR | |
| SCHEMBL5164006 | 0.86 | ALDH1A1 (0.42) | USP2ALDH1A1HTTTSHRHSD17B10 | |
| SCHEMBL25996472 | 0.86 | USP2 (0.42) | USP2ALDH1A1HTTFFAR4FFAR1 | |
| SCHEMBL216630 | 0.84 | ALDH1A1 (0.40) | USP2ALDH1A1HTTTSHRCYP1A2 | |
| SCHEMBL28146059 | 0.84 | USP2 (0.45) | USP2HTTFFAR4FFAR1TSHR | |
| SCHEMBL25996474 | 0.84 | USP2 (0.45) | USP2ALDH1A1HTTFFAR4FFAR1 | |
| SCHEMBL60499 | 0.83 | USP2 (0.55) | USP2HTTFFAR4FFAR1NFKB1 | |
| SCHEMBL3684759 | 0.83 | USP2 (0.55) | USP2HTTFFAR4FFAR1NFKB1 | |
| SCHEMBL21632196 | 0.82 | USP2 (0.48) | USP2ALDH1A1HTTTSHRCYP1A2 | |
| SCHEMBL6017977 | 0.82 | FFAR4 (0.39) | USP2ALDH1A1HTTFFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10759907-B2 | Defined monomer sequence polymers | IP2IPO INNOVATIONS LIMITED (GB) | 2020-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10759907-B2 | Defined monomer sequence polymers | SAMM50, PARG, PARN | USP2 3533/4885ALDH1A1 3880/4885HTT 2375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.